Kazuhiro Matsui Selected Research

Glyceraldehyde 3-Phosphate (Glyceraldehyde 3 Phosphate)

4/2009	Time course of housekeeping gene expression changes in diffuse alveolar damage induced by hyperoxia exposure in mice.
9/2008	Novel transcript profiling of diffuse alveolar damage induced by hyperoxia exposure in mice: normalization by glyceraldehyde 3-phosphate dehydrogenase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuhiro Matsui Research Topics

Disease

5	Neoplasms (Cancer) 01/2007 - 04/2004
2	Carcinoma (Carcinomatosis) 09/2012 - 12/2003
2	Hyperoxia 04/2009 - 09/2008
2	Carcinoid Tumor (Carcinoid) 09/2005 - 02/2004
2	Stomach Neoplasms (Stomach Cancer) 12/2004 - 04/2004
1	Hypotension (Low Blood Pressure) 05/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2016
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 05/2016
1	Stroke (Strokes) 05/2016
1	Autosomal Dominant Polycystic Kidney (ADPKD) 05/2016
1	Vertebrobasilar Insufficiency 05/2016
1	Pathologic Constriction (Stenosis) 09/2012
1	Acute Lung Injury 03/2008
1	Lung Injury 03/2008
1	Ascites 09/2005
1	Carcinogenesis 01/2005
1	Polyps 01/2005
1	Colorectal Neoplasms (Colorectal Cancer) 01/2005
1	Adenocarcinoma 04/2004
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2003
1	Pulmonary Hypertension 01/2002

Drug/Important Bio-Agent (IBA)

3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2005 - 12/2003
2	Oxidoreductases (Dehydrogenase)IBA 04/2009 - 09/2008
2	Glyceraldehyde 3-Phosphate (Glyceraldehyde 3 Phosphate)IBA 04/2009 - 09/2008
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2016
1	AnticoagulantsIBA 05/2016
1	argatroban (MPQA)FDA Link 05/2016
1	Biological ProductsIBA 09/2012
1	Ribosomal Proteins (Ribosomal Protein)IBA 04/2009
1	Claudin-1IBA 04/2009
1	Galectin 3 (LGALS3)IBA 04/2009
1	Karyopherins (Importin)IBA 04/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2009
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2009
1	Muramidase (Lysozyme)IBA 04/2009
1	Surface-Active Agents (Surfactants)IBA 04/2009
1	Protein CIBA 04/2009
1	Messenger RNA (mRNA)IBA 04/2009
1	Peptidoglycan (Murein)IBA 03/2008
1	LipopolysaccharidesIBA 03/2008
1	NF-kappa B (NF-kB)IBA 03/2008
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2007
1	Carboplatin (JM8)FDA LinkGeneric 01/2007
1	Octreotide (Sandostatin)FDA LinkGeneric 09/2005
1	Cisplatin (Platino)FDA LinkGeneric 09/2005
1	AntigensIBA 07/2005
1	Aromatase (CYP19)IBA 06/2005
1	Monoclonal AntibodiesIBA 01/2005
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2005
1	LuciferasesIBA 12/2004
1	Proteins (Proteins, Gene)FDA Link 04/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2004
1	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2004
1	Factor VIII (Coagulation Factor VIII)IBA 01/2002
1	VimentinIBA 01/2002
1	Endothelin-1 (Endothelin 1)IBA 01/2002
1	Matrix Metalloproteinases (MMPs)IBA 01/2002
1	Collagen Type IV (Type IV Collagen)IBA 01/2002
1	DesminIBA 01/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2007 - 09/2005
1	Renal Dialysis (Hemodialysis) 05/2016
1	Intravenous Infusions 09/2012
1	Chemoprevention 01/2005
1	Gastrectomy 04/2004